UnitedHealthcare Pharmacy
Clinical Pharmacy Programs
Program Number 2025 P 2069-16
Program Prior Authorization/Non-Formulary
Medication Abbott Diabetic Meters (e.g. FreeStyle Freedom Lite, FreeStyle
InsuLinx, FreeStyle Lite, FreeStyle Neo, Precision Xtra,) Abbott Test
Strips (e.g. FreeStyle Insulinx, FreeStyle Lite, FreeStyle, FreeStyle
Precision Neo, Precision Xtra), Ascensia Diabetic Meters, excluding
Contour Next Meters* (e.g. Contour, Contour Next Link), Ascensia
Test Strips, excluding Contour Next* Test Strips (e.g. Contour),
Roche Diabetic Meters, excluding Accu-Chek Guide* and Accu-
Chek Guide Me* (e.g. Accu-Chek Aviva Plus, ), Roche Test Strips,
excluding Accu-Chek Guide* (e.g. Accu-Chek Aviva Plus, Accu-
Chek Smartview)
P&T Approval Date 10/2015, 10/2016, 10/2017, 3/2018, 6/2018, 2/2019, 3/2020, 7/2020,
9/2020, 10/2020, 2/2021, 7/2021, 2/2022, 3/2023, 3/2024, 4/2025
Effective Date 7/1/2025
1. Background:
The American Diabetes Association (ADA) recommends routine blood glucose monitoring in
patients using insulin therapy. The ADA also notes that blood glucose monitoring may be helpful
to guide treatment decisions for patients using noninsulin therapies. The ADA does not
differentiate between brands of diabetic meters or test strips in their recommendation.
This program allows coverage of non-preferred test strips if utilization of a OneTouch or Contour
Next diabetic meter/test strip is unsafe, inaccurate or not feasible.
2. Coverage Criteriaa,b:
A. Test Strips and Meters** (excluding Accu-Chek Guide, Accu-Chek Guide Me, OneTouch
and Contour Next*) will be approved based on the following:
1. Submission of medical records documenting a physical or mental limitation that makes
utilization of one of the following diabetic meters/test strips product unsafe, inaccurate or
otherwise not feasible (e.g. manual dexterity):
a. OneTouch Ultra 2 Meter (OneTouch Ultra Test Strips)
b. OneTouch Verio Flex Meter (OneTouch Verio Test Strips)
c. OneTouch Verio Reflect Meter (OneTouch Verio Test Strips)
d. Contour Next One Meter (Contour Next Test Strips)
e. Contour Next EZ Meter (Contour Next Test Strips)
f. Contour Next Gen Meter (Contour Next Test Strips)
Authorization will be issued for 12 months.
© 2025 UnitedHealthcare Services, Inc.
1
a State mandates may apply. Any federal regulatory requirements and the member specific
benefit plan coverage may also impact coverage criteria. Other policies and utilization
management programs may apply.
b In Florida, Maine, Tennessee, and Texas only, diabetes medications may be approved based on
both of the following: 1) Provider attests use of this product is medically necessary; and- 2) If
applicable, clinical characteristics exist that preclude the use of the covered preferred
alternative(s) and use of the covered preferred alternative(s) could result in worsening of
patient’s condition or inadequate treatment (document alternatives and clinical information
related to worsening/inadequate treatment).
3. Additional Clinical Rules:
• Notwithstanding Coverage Criteria, UnitedHealthcare may approve initial and re-authorization
based solely on previous claim/medication history, diagnosis codes (ICD-10) and/or claim logic.
Use of automated approval and re-approval processes varies by program and/or therapeutic class.
• Supply limitations may be in place.
*Accu-Chek Guide Meter, Accu-Chek Guide Me Meter, Accu-Chek Guide test strips, Contour Next
test strips, Contour Next Meter, Contour Next One Meter, and Contour Next EZ Meter are covered
without prior authorization/non-formulary review.
**Typically excluded from coverage.
4. References:
1. American Diabetes Association. Standard of Medical Care in Diabetes - 2025. Diabetes Care
2025;48 (Supplement 1).
Program Prior Authorization/Non-Formulary- Diabetic Meters and Test Strips
Change Control
10/2015 New Program
10/2016 Annual review with administrative changes
Annual review. State mandate reference language updated. Reference
10/2017
updated.
Removed Contour Next from the criteria. Contour Next test strips and
3/2018
meters will be covered without criteria.
Added criteria to allow coverage for FreeStyle Precision Neo blood
6/2018 glucose test strips for FreeStyle Libre Flash Glucose Monitoring system
utilizers.
Added criteria to allow coverage for Contour Next Link meters and test
2/2019 strips for MiniMed insulin pump utilizers. Added criteria for other test
strips and meters which are typically excluded.
3/2020 Annual review. Updated references.
Updated to allow Accu-Chek Guide test strips for Medtronic 780G
7/2020
insulin pump users.
9/2020 Add Oxford effective date, Oxford specific criteria retiring.
Removed Accu-Chek from the criteria. Accu-Chek test strips and
10/2020 meters will be covered without criteria. Added Contour Next products
as a step one option.
Removed Lifescan from description of step one products since the step
2/2021
one products include both Lifescan OneTouch and Contour Next
© 2025 UnitedHealthcare Services, Inc.
2
products.
Updated OneTouch products to add Verio Flex and Verio Reflect, and
7/2021
remove Verio Sync.
2/2022 Added Florida, Maine, Tennessee and Texas mandate language.
3/2023 Removed products which are no longer available from product
examples by manufacturer: Breeze 2, Contour Next USB, Accu-Chek
Aviva Expert, Accu-Chek Compact Plus, Accu-Chek Nano. Removed
criteria for MiniMed pump since these work with covered test strips.
Removed Accu-Chek Combo Insulin Pump from criteria for Roche
products since it is no longer available.
3/2024 Annual review. Updated references.
4/2025 Removed Accu-Chek Compact as this product is off the market.
Removed section for Omnipod EROS/Classic insulin pump as this
product is off the market. Updated OneTouch and Contour meters and
test strips with available products.
© 2025 UnitedHealthcare Services, Inc.
3